{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "In 2016, a 77-year-old man, former smoker, was diagnosed with prostate adenocarcinoma and treated with radiation therapy.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0033541",
              "label": "Adenocarcinoma of prostate",
              "status": "historical",
              "onset_date": "2016"
            }
          ],
          "social_history": [
            {
              "category": "smoking",
              "status": "past",
              "description": "former smoker"
            }
          ],
          "procedures": [
            {
              "name": "C0036307",
              "approach": "other",
              "date": "2016",
              "location": "prostate",
              "performed_by": "unknown",
              "outcome": "unknown"
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "In May 2017, the patient's PSA increased to 5.9 ng/mL, leading to a radical prostatectomy and lymphadenectomy. Histological report indicated stage pT3b N1 Mx R1 prostate adenocarcinoma with a single lymph node metastasis. Adjuvant treatment with leuprorelin was initiated.",
        "clinical_data": {
          "labs": [
            {
              "test": "C0033043",
              "value": "5.9",
              "unit": "ng/mL",
              "timestamp": "2017-05"
            }
          ],
          "procedures": [
            {
              "name": "C0162649",
              "date": "2017-05",
              "outcome": "C0033544"
            },
            {
              "name": "C0347444",
              "date": "2017-05"
            }
          ],
          "diagnoses": [
            {
              "code": "C0678272",
              "label": "adenocarcinoma of prostate",
              "status": "active"
            },
            {
              "code": "C0282607",
              "label": "lymph node metastasis",
              "status": "active"
            }
          ],
          "medications": [
            {
              "drug": "C0023529",
              "start_date": "2017-05"
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Patient admitted to the emergency room for acute respiratory distress.",
        "clinical_data": {
          "HPI": [
            {
              "summary": "Patient admitted to the emergency room for acute respiratory distress."
            }
          ],
          "diagnoses": [
            {
              "code": "57254006",
              "label": "Respiratory distress",
              "status": "active"
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "CT scan showed left pleural effusion, thickening, and nodules of the pleural surface, several mediastinal lymph node metastases, and a bone metastasis in the IX left rib.",
        "clinical_data": {
          "imaging": [
            {
              "type": "CT scan",
              "body_part": "pleural surface",
              "modality": "CT",
              "finding": "left pleural effusion, thickening, and nodules of the pleural surface",
              "date": null
            },
            {
              "type": "CT scan",
              "body_part": "mediastinal lymph node",
              "modality": "CT",
              "finding": "several mediastinal lymph node metastases",
              "date": null
            },
            {
              "type": "CT scan",
              "body_part": "IX left rib",
              "modality": "CT",
              "finding": "bone metastasis in the IX left rib",
              "date": null
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "Pleural effusion cytology came back negative for malignancy.",
        "clinical_data": {
          "labs": [
            {
              "test": "Pleural fluid cytology",
              "value": "negative",
              "finding": "Malignant neoplastic disease (finding)",
              "UMLS_CUI": "C0024685"
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "Ultrasound-guided bone biopsy of the lesion at the IX rib level was carried out.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Bone biopsy",
              "approach": "percutaneous",
              "location": "IX rib",
              "modality": "Ultrasound",
              "date": null
            }
          ]
        }
      }
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "Histology of the bone biopsy revealed malignant cells with adenocarcinoma aggregation. Immunohistochemistry showed the cancer cells were highly immunoreactive for TTF-1 and BerEP4 and negative for the prostatic markers NKX3.1 and PSA, leading to a diagnosis of lung adenocarcinoma.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C34",
              "label": "Lung cancer",
              "status": "active"
            },
            {
              "code": "8140/3",
              "label": "Adenocarcinoma",
              "status": "active"
            }
          ],
          "imaging": [
            {
              "type": "Biopsy",
              "body_part": "Bone",
              "modality": "other",
              "finding": "Malignant cells with adenocarcinoma aggregation",
              "impression": "Lung adenocarcinoma"
            }
          ]
        }
      }
    },
    {
      "id": "N8",
      "label": "Step 8",
      "customData": {
        "node_id": "H",
        "node_step_index": 7,
        "content": "CT scans of the lung lesions after chemotherapy with carboplatin and pemetrexed showed significant response to therapy of mediastinal, pleural, and lung lesions.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Lesion of lung",
              "body_part": "Lung",
              "modality": "CT",
              "finding": "Significant response to therapy of mediastinal, pleural, and lung lesions",
              "date": null
            }
          ],
          "medications": [
            {
              "drug": "carboplatin",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": "Lesion of lung"
            },
            {
              "drug": "pemetrexed",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": "Lesion of lung"
            }
          ]
        }
      }
    },
    {
      "id": "N9",
      "label": "Step 9",
      "customData": {
        "node_id": "I",
        "node_step_index": 8,
        "content": "Next-generation sequencing (NGS) profiling of the rib lesion revealed the TMPRSS2:ERG fusion as a unique alteration. The prostate cancer tissue was positive for the prostate immunohistochemical markers (NKX3.1, PSA) and negative for the lung markers (TTF-1, BerEP4) but harbored the TMPRSS2:ERG fusion as the only molecular alteration.",
        "clinical_data": {
          "imaging": [
            {
              "body_part": "T-0003847",
              "modality": "other",
              "finding": "TMPRSS2:ERG fusion",
              "type": "Next-generation sequencing",
              "impression": "TMPRSS2:ERG fusion"
            }
          ],
          "diagnoses": [
            {
              "code": "C0036033",
              "label": "Prostate Cancer",
              "status": "active"
            }
          ]
        }
      }
    },
    {
      "id": "N10",
      "label": "Step 10",
      "customData": {
        "node_id": "J",
        "node_step_index": 9,
        "content": "August 2019: The patient's serum PSA increased to 2.3 ng/mL. Multiple pleural biopsies were performed to exclude concomitant lung cancer and prostate cancer metastases. Histological diagnosis revealed a poorly differentiated adenocarcinoma positive for the lung markers TTF-1 and CK7 and negative for the prostatic markers (PSA and NKX3.1).",
        "clinical_data": {
          "labs": [
            {
              "test": "Serum prostate-specific antigen",
              "value": "2.3",
              "unit": "ng/mL",
              "timestamp": "2019-08"
            }
          ],
          "procedures": [
            {
              "name": "Biopsy of pleura",
              "date": "2019-08",
              "approach": "other"
            }
          ],
          "diagnoses": [
            {
              "code": "C44190",
              "label": "Poorly differentiated adenocarcinoma",
              "status": "active"
            }
          ]
        }
      }
    },
    {
      "id": "N11",
      "label": "Step 11",
      "customData": {
        "node_id": "K",
        "node_step_index": 10,
        "content": "Patient started on first-line therapy with enzalutamide.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C1024841",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      }
    },
    {
      "id": "N12",
      "label": "Step 12",
      "customData": {
        "node_id": "L",
        "node_step_index": 11,
        "content": "January 2020: Patient admitted to the thoracic surgery ward due to recurrent pleural effusion and respiratory failure. Talc pleurodesis was performed.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "54575003",
              "label": "Pleural effusion",
              "status": "active",
              "onset_date": "2020-01"
            },
            {
              "code": "267036007",
              "label": "Respiratory failure",
              "status": "active",
              "onset_date": "2020-01"
            }
          ],
          "procedures": [
            {
              "name": "429836007",
              "approach": "other",
              "date": "2020-01",
              "location": "Pleural cavity",
              "performed_by": "Thoracic surgeon",
              "outcome": "unknown"
            }
          ]
        }
      }
    },
    {
      "id": "N13",
      "label": "Step 13",
      "customData": {
        "node_id": "M",
        "node_step_index": 12,
        "content": "January 2020: CT scan showed progressive disease with several pleural metastases and bone metastases of the IX and V left ribs with muscular infiltration. PSA level of 1 ng/mL.",
        "clinical_data": {
          "imaging": [
            {
              "type": "CT scan",
              "body_part": "pleura",
              "modality": "CT",
              "finding": "progressive disease with several pleural metastases",
              "date": "2020-01"
            },
            {
              "type": "CT scan",
              "body_part": "rib",
              "modality": "CT",
              "finding": "bone metastases of the IX and V left ribs with muscular infiltration",
              "date": "2020-01"
            }
          ],
          "labs": [
            {
              "test": "Prostate-specific antigen measurement",
              "value": "1",
              "unit": "ng/mL",
              "timestamp": "2020-01"
            }
          ]
        }
      }
    },
    {
      "id": "N14",
      "label": "Step 14",
      "customData": {
        "node_id": "N",
        "node_step_index": 13,
        "content": "February 2020: CT-guided pleural biopsy revealed a papillary poorly differentiated adenocarcinoma",
        "clinical_data": {
          "imaging": [
            {
              "type": "Computed tomography",
              "body_part": "Pleura",
              "modality": "CT",
              "date": "2020-02"
            }
          ],
          "procedures": [
            {
              "name": "Biopsy",
              "approach": "percutaneous",
              "date": "2020-02",
              "location": "Pleura",
              "performed_by": "radiologist",
              "outcome": "papillary poorly differentiated adenocarcinoma"
            }
          ],
          "diagnoses": [
            {
              "code": "C83.9",
              "label": "Papillary poorly differentiated adenocarcinoma",
              "status": "active",
              "onset_date": "2020-02"
            }
          ]
        }
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "PSA increased, leading to radical prostatectomy and lymphadenectomy. Adjuvant treatment with leuprorelin was initiated."
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Patient admitted to the emergency room for acute respiratory distress."
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "CT scan showed left pleural effusion, thickening, and nodules of the pleural surface, several mediastinal lymph node metastases, and a bone metastasis in the IX left rib."
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Pleural effusion cytology came back negative for malignancy."
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Ultrasound-guided bone biopsy of the lesion at the IX rib level was carried out."
      }
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Histology of the bone biopsy revealed malignant cells with adenocarcinoma aggregation. Immunohistochemistry showed the cancer cells were highly immunoreactive for TTF-1 and BerEP4 and negative for the prostatic markers NKX3.1 and PSA, leading to a diagnosis of lung adenocarcinoma."
      }
    },
    {
      "from": "N7",
      "to": "N8",
      "data": {
        "edge_id": "G_to_H",
        "branch_flag": true,
        "content": "CT scans of the lung lesions after chemotherapy with carboplatin and pemetrexed showed significant response to therapy of mediastinal, pleural, and lung lesions."
      }
    },
    {
      "from": "N8",
      "to": "N9",
      "data": {
        "edge_id": "H_to_I",
        "branch_flag": true,
        "content": "Next-generation sequencing (NGS) profiling of the rib lesion revealed the TMPRSS2:ERG fusion as a unique alteration. The prostate cancer tissue was positive for the prostate immunohistochemical markers (NKX3.1, PSA) and negative for the lung markers (TTF-1, BerEP4) but harbored the TMPRSS2:ERG fusion as the only molecular alteration."
      }
    },
    {
      "from": "N9",
      "to": "N10",
      "data": {
        "edge_id": "I_to_J",
        "branch_flag": true,
        "content": "August 2019: The patient's serum PSA increased to 2.3 ng/mL. Multiple pleural biopsies were performed to exclude concomitant lung cancer and prostate cancer metastases. Histological diagnosis revealed a poorly differentiated adenocarcinoma positive for the lung markers TTF-1 and CK7 and negative for the prostatic markers (PSA and NKX3.1)."
      }
    },
    {
      "from": "N10",
      "to": "N11",
      "data": {
        "edge_id": "J_to_K",
        "branch_flag": true,
        "content": "Patient started on first-line therapy with enzalutamide."
      }
    },
    {
      "from": "N11",
      "to": "N12",
      "data": {
        "edge_id": "K_to_L",
        "branch_flag": true,
        "content": "January 2020: Patient admitted to the thoracic surgery ward due to recurrent pleural effusion and respiratory failure. Talc pleurodesis was performed."
      }
    },
    {
      "from": "N12",
      "to": "N13",
      "data": {
        "edge_id": "L_to_M",
        "branch_flag": true,
        "content": "January 2020: CT scan showed progressive disease with several pleural metastases and bone metastases of the IX and V left ribs with muscular infiltration. PSA level of 1 ng/mL."
      }
    },
    {
      "from": "N13",
      "to": "N14",
      "data": {
        "edge_id": "M_to_N",
        "branch_flag": true,
        "content": "February 2020: CT-guided pleural biopsy revealed a papillary poorly differentiated adenocarcinoma"
      }
    }
  ]
}